Seabrook, TX, United States of America

Charlotte Clarke

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignees: The University of Texas System, Vermillion Corporation. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Charlotte Clarke. Retrieved from https://idiyas.com/inventor/charlotte-clarke

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Charlotte Clarke in Ovarian Cancer Research

Introduction

Charlotte Clarke is an accomplished inventor based in Seabrook, TX (US). She has made significant contributions to the field of medical research, particularly in the area of ovarian cancer. Her work focuses on developing biomarkers that can aid in the diagnosis and monitoring of this serious condition.

Latest Patents

Charlotte Clarke holds a patent for her invention titled "Biomarkers for Ovarian Cancer." This patent provides protein-based biomarkers and biomarker combinations that are useful in qualifying ovarian cancer status in a patient. The biomarkers identified in her research can be detected using SELDI mass spectrometry, offering a promising tool for early detection and treatment.

Career Highlights

Throughout her career, Charlotte has worked with notable organizations, including Vermillion Corporation and the University of Texas System. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of her notable coworkers include Eric Thomas Fung and Robert C Bast. Their collective efforts have advanced the understanding of ovarian cancer and the development of effective diagnostic tools.

Conclusion

Charlotte Clarke's innovative work in identifying biomarkers for ovarian cancer represents a significant advancement in medical research. Her contributions have the potential to improve patient outcomes and enhance the early detection of this disease.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…